PHARMA-VENTURES (INTERNATIONAL) PVT.LTD.
PHARMA-VENTURES (INTERNATIONAL) PVT.LTD. is a DELHI based PRIVATE LIMITED company, Registered at dated 25-FEB-1999 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of PHARMA-VENTURES (INTERNATIONAL) PVT.LTD. is U99999DL1999PTC098579 and registration number is 098579.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies DELHI India. Authorized share capital of PHARMA-VENTURES (INTERNATIONAL) PVT.LTD. is Rs. 15000000 and its paid up capital is Rs. 12310000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 2013-03-31 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 0.
PHARMA-VENTURES (INTERNATIONAL) PVT.LTD. has 3 directors MEDHATITHI JHA, SARAWJEET SINGH, JUHI JHA,
The registered Email address of PHARMA-VENTURES (INTERNATIONAL) PVT.LTD. is fcaskg@gmail.com and its registered address is W-152 GREATER KAILSAH -I NEW DELHI DELHI INDIA 110048 DELHI DELHI india 110048.
The current status of PHARMA-VENTURES (INTERNATIONAL) PVT.LTD. shows as CONVERTED TO LLP AND DISSOLVED
COMPANY BASIC DETAILS
PHARMA-VENTURES (INTERNATIONAL) PVT.LTD.
DELHI
CONVERTED TO LLP AND DISSOLVED
U99999DL1999PTC098579
25 FEB 1999
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
15000000
12310000
2013-03-31
CONTACT DETAILS
110048
INDIA
W-152 GREATER KAILSAH -I NEW DELHI DELHI INDIA 110048
fcaskg@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
00720174 | MEDHATITHI JHA | Director | 25/02/1999 |
01230727 | SARAWJEET SINGH | Director | 25/02/1999 |
02818612 | JUHI JHA | Director | 31/03/2009 |
Details Updated by Companies
Quick Links
- All Registered company of DELHI
- Company Registered in DELHI
- All Registered company of SOUTH DELHI in DELHI
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.